Literature DB >> 28375659

Cardiopulmonary Exercise Test in Hypertrophic Cardiomyopathy.

Damiano Magrì1, Caterina Santolamazza1.   

Abstract

Understanding the functional limitation in hypertrophic cardiomyopathy, the most common inherited heart disease, is challenging. In addition to the occurrence of disease-related complications, several factors are potential determinants of exercise limitation, including left ventricular hypertrophy, myocardial fiber disarray, left ventricular outflow tract obstruction, microvascular ischemia, and interstitial fibrosis. Furthermore, drugs commonly used in the daily management of these patients may interfere with exercise capacity, especially those with a negative chronotropic effect. Cardiopulmonary exercise testing can safely and objectively evaluate the functional capacity of these patients and help the physician in understanding the mechanisms that underlie this limitation. Features that reduce exercise capacity may predict progression to heart failure in these patients and even the risk of sudden cardiac death.

Entities:  

Keywords:  cardiopulmonary exercise testing; functional capacity; hypertrophic cardiomyopathy; prognosis

Mesh:

Year:  2017        PMID: 28375659     DOI: 10.1513/AnnalsATS.201611-884FR

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  6 in total

1.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

Review 2.  Risk stratification in hypertrophic cardiomyopathy.

Authors:  S Marrakchi; I Kammoun; E Bennour; L Laroussi; S Kachboura
Journal:  Herz       Date:  2018-04-25       Impact factor: 1.443

3.  Pressure-Strain Loops, a Novel Non-invasive Approach for Assessment of Children with Cardiomyopathy.

Authors:  Doaa M Aly; Michael Nguyen; Scott Auerbach; Christopher Rausch; Bruce Landeck; Michael V DiMaria
Journal:  Pediatr Cardiol       Date:  2022-04-11       Impact factor: 1.838

Review 4.  Risk stratification in cardiomyopathy.

Authors:  Gianfranco Sinagra; Cosimo Carriere; Francesco Clemenza; Chiara Minà; Francesco Bandera; Denise Zaffalon; Paola Gugliandolo; Marco Merlo; Marco Guazzi; Piergiuseppe Agostoni
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

5.  Predictors of Exercise Capacity in Patients with Hypertrophic Obstructive Cardiomyopathy.

Authors:  Joshua R Smith; Jose R Medina-Inojosa; Veronica Layrisse; Steve R Ommen; Thomas P Olson
Journal:  J Clin Med       Date:  2018-11-18       Impact factor: 4.241

6.  Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy.

Authors:  Giovanna Gallo; Vittoria Mastromarino; Giuseppe Limongelli; Giulio Calcagni; Antonello Maruotti; Luca Ragni; Fabio Valente; Maria Beatrice Musumeci; Rachele Adorisio; Marta Rubino; Camillo Autore; Damiano Magrì
Journal:  Biomolecules       Date:  2021-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.